Warning Label Final Guidance Recommends Use Of Numeric Adverse Reaction Rates
This article was originally published in The Pink Sheet Daily
Also, known or possible hypersensitivity reactions should be listed under contraindications in drug labeling, FDA says in final guidance.
You may also be interested in...
US guidances will be shorter and use a series of bullet points to communicate key ideas, replacing the current longer and wordier format.
The labeling rule “is not just a format revision. It is also a content revision,” Deputy Commissioner Woodcock says.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.